CDKN2A and cancer: Mouse models lacking either p16INK4A, p19ARF, which is the mouse homolog of human p14ARF, or both, always show increased incidence of various tumors, while human cancers frequently display either deletion of the whole gene locus, affecting both alternative reading frames, or specific silencing of either the p16INK4A or p14ARF promoter by methylation (33).